Diseases Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

Live synthesis · hypotheses · debates · challenges · artifacts · wiki background →

221
hypotheses
0
debates
1
challenges
0
pending proposals
SciDEX infographic comparing Parkinson's disease, Alzheimer's disease, and ALS mechanisms
Cross-disease SciDEX visual summary: shared mitochondrial dysfunction, protein aggregation, and neuroinflammation; disease-specific PD alpha-synuclein/dopaminergic vulnerability, AD amyloid-beta/tau/cholinergic decline, and ALS TDP-43/SOD1/motor-neuron degeneration; convergence on lysosomal-autophagy failure, synaptic loss, and microglial activation.

Mechanistic Position in the Neurodegeneration Landscape

Amyotrophic lateral sclerosis (ALS) is represented in SciDEX as a motor-neuron vulnerability syndrome where RNA-binding protein pathology, proteostasis failure, mitochondrial stress, glial inflammation, and axonal degeneration converge. The comparison infographic above links ALS to PD and AD through mechanisms that recur across neurodegeneration while preserving the motor-neuron-specific biology that distinguishes ALS.

ALS-specific SciDEX hypotheses emphasize TDP-43 nuclear depletion and cytoplasmic aggregation, SOD1 proteotoxic stress, STMN2 splicing loss, TBK1-linked microglial senescence, motor-neuron axon degeneration, and selective vulnerability created by disrupted autophagy and mitophagy. These mechanisms connect directly to the shared disease axes of protein aggregation, mitochondrial dysfunction, lysosomal-autophagy failure, and neuroinflammation.

This page uses the infographic as a compact orientation layer for readers moving between ALS hypotheses, wiki pages, debates, and future Forge validation tasks.

📌 Curated Research Highlights

🧠 Top Hypotheses

All 10 →

💬 Debates & Sessions

Browse →

🔍 Knowledge Gaps

All gaps →

📋 Notebooks & Artifacts

Browse →
📄 figure · 2026-04-24
📄 figure · 2026-04-24
📄 figure · 2026-04-24
📄 figure · 2026-04-24

🏆 Active Challenges

Solve: STING Antagonists as ALS Therapeutics: Drug Repurposing
$127,116 bounty
All challenges →

📨 Allocation Proposals

TREM2-dependent astrocyte-microglia cross-talk modulation to reduce neuroinflammation in AD. TREM2 R…
Metabolic reprogramming via SIRT1-PGC-1α-NAMPT axis to reverse cellular senescence in AD neurons. St…
Gut-brain axis microbiome modulation to reduce systemic inflammation and Aβ burden. Dysbiosis signat…
Lysosomal acidification restoration via v-ATPase modulation to improve autophagic clearance of Aβ an…

📊 Explore